The Role of Forced Degradation in Method Development, Manufacturability, and CMC Strategy Forced degradation studies are critical in biologics development, particularly for monoclonal antibodies (mAbs). These studies simulate long-term environmental stressors to uncover degradation pathways and ensure the stability of critical quality attributes (CQAs), aiding in robust chemistry, manufacturing, and controls (CMC) strategies and regulatory compliance.
https://www.pharmtech.com/view..../the-role-of-forced-

CHMP Recommends argenx Treatment for Chronic Inflammatory Demyelinating Polyneuropathy The company said that Vyvgart (efgartigimod alfa) is the first novel mechanism of action for CIDP treatment in more than 30 years.
https://www.pharmtech.com/view..../chmp-recommends-arg

Mosaic therapeutics expands pipeline with Astex deal https://pharmatimes.com/news/m....osaic-therapeutics-e

Argenx receives positive CHMP opinion for CIDP treatment https://pharmatimes.com/news/a....rgenx-receives-posit

CN Bio Forms Strategic Partnership with Pharmaron to Develop OOC Technologies Under the partnership, Pharmaron will validate and promote the application of CN Bio’s PhysioMimix technology and will integrate OOC technologies into its R&D platform.
https://www.pharmtech.com/view..../cn-bio-forms-strate